Atlas Trials

Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)

Clinical trial NCT06416683 · COMPLETED

Trial details

NCT number
NCT06416683
Sponsor
University Hospital, Caen
Status
COMPLETED
Study type
OBSERVATIONAL
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Start date
2021-01-01
Primary completion
2023-06-30
Enrollment
109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.